Inhibitory effect of oxymatrine on serum hepatitis B virus DNA in HBV transgenic mice

Table 1 Results of HBV DNA quantitation in transgenic mice before and after oxymatrine treatment (fg/mL) (n, mean ± SD)

Group	Group A		Group B		Group C
Pre-treatment	9	10 933.33 ± 5 591.06	8	12 762.5 ± 4 891.96	9	10 164.44 ± 5 842.93
Post-treatment	9	10 864.44 ± 5 492.81	8	5 898.375 ± 4 597.09	9	2 426.33 ± 1 563.12bd

^bP < 0.01 vs before treatment,

^dP < 0.01 (vs after treatment in groups A and B).